FOXN1 and immune system disorder: The clustering of malignancies and infections in this case over a short time period supports the hypothesis of immune dysfunction, whilst also emphasising the importance of longitudinal monitoring for patients with FOXN1 mutations, particularly following cytotoxic therapy.